Susquehanna International Group, LLP Evogene Ltd. Call Options Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
Call Options
3 transactions
Others Institutions Holding EVGN
# of Institutions
30Shares Held
3.94MCall Options Held
400Put Options Held
0-
Silverarc Capital Management, LLC3.08MShares$7.88 Million0.57% of portfolio
-
Morgan Stanley New York, NY218KShares$559,2440.0% of portfolio
-
Eidelman Virant Capital117KShares$299,5200.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC67.3KShares$172,3770.0% of portfolio
-
Ubs Group Ag66KShares$168,9720.0% of portfolio
About Evogene Ltd.
- Ticker EVGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,202,000
- Market Cap $105M
- Description
- Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...